"10.1371_journal.pone.0111020","plos one","2014-10-24T00:00:00Z","Robert Schwenk; Margot DeBot; Michael Porter; Jennifer Nikki; Lisa Rein; Roberta Spaccapelo; Andrea Crisanti; Paul D Wightman; Christian F Ockenhouse; Sheetij Dutta","Malaria Vaccine Branch, Walter Reed Army Institute of Research, Silver Spring, MD, United States of America; 3M Drug Delivery Systems, St. Paul, MN, United States of America; Department of Experimental Medicine, University of Perugia, Perugia, Italy; Imperial College London, London, United Kingdom","Conceived and designed the experiments: R. Schwenk PW CO SD. Performed the experiments: R. Schwenk MD MP JN LR SD. Analyzed the data: R. Schwenk SD. Contributed reagents/materials/analysis tools: R. Spaccapelo AC. Wrote the paper: R. Schwenk MD SD.","SD is named as an inventor on a patent for expression of CSP described here. However this does not influence the authors adherence to the journals policy. CO was active duty military personnel at the time he contributed to this work; SD is a US Government employee. The work of these individuals was prepared as part of official government duties. Title 17 U.S.C. ยง105 provides that Copyright protection under this title is not available for any work of the United States Government. Title 17 U.S.C. ยง101 defines a U.S. Government work as a work prepared by a military service member or employee of the U.S. Government as part of that persons official duties. The views expressed in this article are those of the authors and do not necessarily reflect the official policy or position of the Department of the Army, the Department of Defense, or the U.S. Government. Disclaimer 1: Paul Wightman was employed by 3M Drug Delivery Systems at the time this work was performed. The authors declare the his employment at 3M did not alter data analysis and interpretation and his affiliation with 3M will not alter their adherence to all PLOS ONE policies on sharing data and materials. Disclaimer 2: The corresponding author Sheetij Dutta has filed a patent application (PLASMODIUM FALCIPARUM CIRCUMSPOROZOITE VACCINE GENE OPTIMIZATION FOR SOLUBLE PROTEIN EXPRESSION; US application #20130259890), relating to the recombinant CSP vaccine describe here. This filing will not alter the authors adherence to all PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.","2014","10","Robert Schwenk","RS",10,TRUE,1,1,1,1,TRUE,TRUE,TRUE,7,"2;3;4;7;8;9;10",TRUE
